Residents face deadline to file claim on $125M settlement

File image

INDIANAPOLIS — Indiana residents have until April 13 to file a claim and receive money from a $125 million multi-state settlement with biopharmaceutical company Cephalon.

The Indiana attorney general’s office says the settlement resolves allegations of unlawful, anticompetitive conduct involving the drug Provigil, which is used to treat adult patients with excessive sleepiness.

It says Cephalon engaged in “pay-for-delay” conduct, paying a would-be generic competitor to delay their entry into the market to keep prices at artificially high levels.

Eligible Indiana residents include those who purchased brand-name Provigil or generic modafinal from June 24, 2006 to March 31, 2012. The drugs are used to treat symptoms associated with narcolepsy, obstructive sleep apnea and shift work disorder.

For more info on the settlement, click here.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s